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were actually designed and reported previously by Chen et al. 8 in a study on the use of rapid real-time PCR assays for the quantification of erm genes in manure, compost, lagoons and a bioreactor. Clearly, when used for Haemophilus influenzae they gave false positives and another primer set should have been used for detection of the genes in question. The erm(A) and mef(A) primer sets used for our H. influenzae study (Table 1) , 2 and that do not produce false-positive PCR results, have been described previously. 3 -7 In addition to confirming our positive PCR results by hybridization of the PCR products with internal probes, we verified that the macrolide genes are on mobile elements by selecting 25 H. influenzae isolates as donors for mating experiments with H. influenzae Rd and/or Enterococcus faecalis JH2-2 as recipients. 2 All 25 donors were able to transfer macrolide resistance to recipients at a frequency ranging from 10 27 to 10 210 /recipient. 2 The resulting transconjugants were resistant to macrolides and had erm genes and/or a mef(A) gene that were originally found in the donor strains. 2 Mutations do not normally transfer by conjugation (M. C. Roberts, unpublished observations).
We should emphasize that a study of 172 H. influenzae isolates from Australia should not be considered representative of H. influenzae across the world. A possible reason for differences between the USA and Australian isolates may be the type of patients included in the Australian study. 1 Only 15.7% (27/172) of the Australian H. influenzae isolates came from patients with exposure to azithromycin compared with 106 USA cystic fibrosis isolates that were from patients participating in a clinical study where 50% had extensive azithromycin therapy three times per week. 2 Only 7 Australian isolates were macrolide resistant compared with 27 macrolide-resistant isolates in the USA study.
1,2 Therefore, based on different populations (azithromycin exposed) and a low number of isolates resistant to macrolides, there could easily be differences in the distribution of erm/mef(A) genes among H. influenzae from different patient populations even within a single city.
It Internal primer assays. Without this being done, there is no scientific evidence for the authors to conclude that 'It is interesting to speculate as to whether some of the positive results in the Roberts et al.
2 study, particularly for mef(A) and erm(A), could have been similar false positives', 1 especially since our strains were internal probe positive and the 25 isolates used for mating experiments could move macrolide resistance by conjugation. 2 It would have been interesting if the resistant Australian strains were tested on their ability to transfer macrolide resistance to a recipient, which would have indicated the presence of a known or unidentified/novel acquired macrolide resistance gene. Our group and collaborators from Chile and Germany have reported previously that it is possible to transfer tetracycline resistance from Chilean salmon farm isolates (Pseudomonas putida and Providencia rettgeri) with unknown tet genes to recipient Escherichia coli strains HB101 and DH5a. 9 One last note: there is no mef(E) gene, it is just a variant of mef(A) with .80% amino acid identity to mef(A) and it is not recognized as a separate gene.
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